Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$209.01 - $232.56 $105,341 - $117,210
-504 Reduced 3.77%
12,871 $2.81 Million
Q4 2023

Feb 05, 2024

SELL
$197.69 - $227.29 $85,402 - $98,189
-432 Reduced 3.13%
13,375 $3.04 Million
Q3 2023

Nov 07, 2023

SELL
$201.05 - $221.7 $16,888 - $18,622
-84 Reduced 0.6%
13,807 $2.78 Million
Q2 2023

Aug 04, 2023

SELL
$211.93 - $241.33 $14,623 - $16,651
-69 Reduced 0.49%
13,891 $3.35 Million
Q1 2023

May 08, 2023

SELL
$213.32 - $257.83 $5,972 - $7,219
-28 Reduced 0.2%
13,960 $3.2 Million
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $61,116 - $74,691
-300 Reduced 2.1%
13,988 $3.29 Million
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $80,490 - $103,040
-393 Reduced 2.68%
14,288 $2.93 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $3.14 Million - $4.08 Million
14,681 New
14,681 $3.44 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.